Home Cart Sign in  
Chemical Structure| 1314324-00-9 Chemical Structure| 1314324-00-9

Structure of 1314324-00-9

Chemical Structure| 1314324-00-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 1314324-00-9 ]

CAS No. :1314324-00-9
Formula : C9H11ClFN
M.W : 187.64
SMILES Code : N[C@H]1[C@H](C2=CC=C(F)C=C2)C1.[H]Cl
MDL No. :MFCD28118781
InChI Key :ZQPBZLHQLCAFOQ-OULXEKPRSA-N
Pubchem ID :56666982

Safety of [ 1314324-00-9 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Computational Chemistry of [ 1314324-00-9 ] Show Less

Physicochemical Properties

Num. heavy atoms 12
Num. arom. heavy atoms 6
Fraction Csp3 0.33
Num. rotatable bonds 1
Num. H-bond acceptors 2.0
Num. H-bond donors 1.0
Molar Refractivity 48.54
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

26.02 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

0.0
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

2.39
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

2.86
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

2.51
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

2.19
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

1.99

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-2.81
Solubility 0.289 mg/ml ; 0.00154 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-2.58
Solubility 0.496 mg/ml ; 0.00264 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-2.67
Solubility 0.403 mg/ml ; 0.00215 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-5.75 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

2.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.97

Application In Synthesis of [ 1314324-00-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1314324-00-9 ]

[ 1314324-00-9 ] Synthesis Path-Downstream   1~12

  • 1
  • [ 1314323-96-0 ]
  • [ 1314324-00-9 ]
YieldReaction ConditionsOperation in experiment
35% With hydrogenchloride; In ethyl acetate; at 0℃; General procedure: Carbamate derivative 3 was taken up in anhydrous EtOAc cooled at 0 C and HCl(g) was bubbled into the solution for 40-90 min. The reaction was monitored by TLC. The resulting HCl salt was filtered and washed with diethyl ether.
  • 2
  • [ 405-99-2 ]
  • [ 1314324-00-9 ]
  • 3
  • [ 161711-27-9 ]
  • [ 1314324-00-9 ]
  • 4
  • (1R,2R)-trans-2-(4-fluorophenyl)-cyclopropane-1-carboxylic acid t-butyl ester [ No CAS ]
  • [ 1314324-00-9 ]
  • 5
  • [ 1314324-00-9 ]
  • methyl 1-[4-formyl-4-(methoxymethyl)piperidin-1-yl]methyl}cyclobutanecarboxylate [ No CAS ]
  • methyl 1-((4-((((1R,2S)-2-(4-fluorophenyl)cyclopropyl)amino)methyl)-4-(methoxymethyl)piperidin-1-yl)methyl)cyclobutanecarboxylate [ No CAS ]
YieldReaction ConditionsOperation in experiment
N,N-Diisopropylethylamine (35 μL, 0.20 mmol) was added to a mixture of (1R,2S)-2-(4-fluorophenyl)cyclopropanamine hydrochloride (Enamine, catNo.EN300-189082: 19 mg, 0.10 mmol) in methylene chloride (0.7 mL), followed by the addition of methyl 1-[4-formyl-4-(methoxymethyl)piperidin-1-yl]methyl}cyclobutanecarboxylate (42 mg, 0.15 mmol). The resulting mixture was stirred at room temperature for 1 h, then sodium triacetoxyborohydride (69 mg, 0.33 mmol) was added. The mixture was stirred at room temperature overnight then diluted with methylene chloride, washed with 1N NaOH, water and brine. Layers were separated and the organic layer was dried over Na2SO4, filtered and concentrated in vacuo. The intermediate methyl 1-((4-((((1R,2S)-2-(4-fluorophenyl)cyclopropyl)amino)methyl)-4-(methoxymethyl)piperidin-1-yl)methyl)cyclobutanecarboxylate was dissolved in MeOH/THF (0.1 mL/0.2 mL) then 6N NaOH (0.5 mL) was added. The mixture was stirred at 30 C. overnight, cooled to room temperature and purified by prep-HPLC (pH=2, acetonitrile/water+TFA) to give the desired product as the TFA salt. LC-MS calculated for C23H34FN2O3 [M+H]+: m/z=405.3. found 405.2.
  • 6
  • [ 1314324-00-9 ]
  • N-[(2S)-1-(4-methanesulfonylpiperazin-1-yl)-1,6-dioxohexan-2-yl]-N-methylbenzamide [ No CAS ]
  • N-[(2S)-6-[[(1R,2S)-2-(4-fluorophenyl)cyclopropyl]amino]-1-(4-methanesulfonylpiperazin-1-yl)-1-oxohexan-2-yl]-N-methylbenzamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
34% With sodium tris(acetoxy)borohydride; In dichloromethane; at 20℃; for 1.0h; Into a 100-mL round-bottom flask, was placed a solution of N-[(2S)-1-(4-methanesulfonylpiperazin-1-yl)-1,6-dioxohexan-2-yl]-N-methylbenzamide (150 mg, 0.37 mmol, 1.00 equiv) in dichloromethane (60 mL), <strong>[1314324-00-9](1R,2S)-2-(4-fluorophenyl)cyclopropan-1-amine hydrochloride</strong> (100 mg, 0.53 mmol, 1.45 equiv), Na(OAc)3BH (100 mg). The resulting solution was stirred for 1 h at room temperature. After the reaction was complete, the reaction was then quenched by the addition of water (100 mL). The resulting mixture was extracted with ethyl acetate (4×50 mL) and the organic layers were combined. The resulting mixture was washed with brine (3×50 mL), dried over anhydrous sodium sulfate and filtered. The filtrate was concentrated under vacuum. The obtained residue was purified by silica gel column chromatography using ethyl acetate/petroleum ether (1/3). This resulted in 67 mg (34%) of N-[(2S)-6-[[(1R,2S)-2-(4-fluorophenyl)cyclopropyl]amino]-1-(4-methanesulfonylpiperazin-1-yl)-1-oxohexan-2-yl]-N-methylbenzamide as an off-white solid. 1H NMR (400 MHz, CDCL3, ppm): 7.30-7.45 (m, 5H), 6.90-7.10 (m, 4H), 5.55-5.59 (m, 1H), 3.75-3.85 (m, 4H), 3.25-3.35 (m, 4H), 2.83-2.94 (m, 8H), 2.40-2.48 (m, 1H), 1.71-2.25 (m, 5H), 1.25-1.51 (m, 3H), 1.02-1.14 (m, 1H). LC/MS (ES, m/z): 545 [M+H]+.
  • 7
  • trans-N-(2-(4-fluorophenyl)cyclopropyl)pivalamide [ No CAS ]
  • [ 1314324-00-9 ]
  • 8
  • [ 1314324-00-9 ]
  • 1-(4-(1H-1,2,3-triazol-1-yl)benzoyl)-2-carbomethoxy aziridine [ No CAS ]
  • methyl 3-[[(1R,2S)-2-(4-fluorophenyl)cyclopropyl]amino]-2-[[4-(1H-1,2,3-triazol-1-yl)phenyl]formamido]propanoate [ No CAS ]
YieldReaction ConditionsOperation in experiment
43% With triethylamine; In acetonitrile; at 80℃; for 16.0h; Methyl 3-[[(1R,2S)-2-(4-fluorophenyl)cyclopropyl]amino]-2-[[4-(1H-1,2,3-triazol-1-yl)phenyl]formamido]propanoate (0322) In a 50-mL round-bottom flask were combined the compound produced in the previous step (1.5 g, 5.51 mmol, 1.00 equiv), CH3CN (20 mL), (1S,2R)-2-(4-fluorophenyl)cyclopropan-1-amine hydrochloride (2.6 g, 13.86 mmol, 2.50 equiv) and Et3N (1.4 g, 13.84 mmol, 2.48 equiv). The resulting solution was stirred for 16 h at 80 C. in an oil bath, then diluted with 50 ml of EtOAc, washed with 1×30 mL of water and 1×30 mL of brine, dried over Na2SO4 and concentrated under vacuum. The residue was applied onto a silica gel column with EtOAc/petroleum ether (2:1), affording 1 g (43%) of PH-IMA-2013-003-362-11 as an off-white solid.
  • 9
  • [ 1314324-00-9 ]
  • (S)-methyl 1-[4-(1H-pyrazol-1-yl)benzoyl]aziridine-2-carboxylate [ No CAS ]
  • [ 76-05-1 ]
  • (S)-methyl 2-[4-(1H-pyrazol-1-yl)benzamido]-3-[(1R,2S)-2-(4-fluorophenyl)cyclopropyl]amino}propanoate trifluoroacetic acid salt [ No CAS ]
YieldReaction ConditionsOperation in experiment
14% (S)-methyl 2-[4-(1H-pyrazol-1-yl)benzamido]-3-[(1R,2S)-2-(4-fluorophenyl)cyclopropyl]amino}propanoate [7] (0576) To a solution of 5 (450 mg, 1.66 mmol) in acetonitrile (10 mL) was added 6 (776 mg, 4.15 mmol) followed by triethylamine (0.6 mL, 4.15 mmol). The reaction mixture was stirred under nitrogen atmosphere at 80 C. for 16 h. After this time, the reaction mixture was cooled and diluted with water (10 mL). The layers were separated and the aqueous layer was extracted with ethyl acetate (2×20 mL). The combined organic layers were washed with brine (10 mL), dried over anhydrous sodium sulfate and concentrated under reduced pressure. The resulting residue was purified by MS-triggered preparative HPLC to afford 7.TFA (100 mg, 14%) as a brown red gum. MS-triggered Preparative HPLC purifications were performed using a Sunfire C18 column, OBD, 10μ (30×250 mm) with UV detection at 220 nm using a solvent gradient program (15% to 55% acetonitrile/water with 0.1% trifluoroacetic acid).
  • 10
  • [ 1314324-00-9 ]
  • N-[(2S)-1-(4-(methyl)piperazin-1-yl)-5-[[(1R,2S)-2-(4-fluorophenyl)cyclopropyl]amino]-1-oxopentan-2-yl]-4-(1H-1,2,3-triazol-1-yl)benzamide [ No CAS ]
  • 11
  • [ 1314324-00-9 ]
  • N-[(2S)-1-(4-(methyl)piperazin-1-yl)-5-[[(1R,2S)-2-(4-fluorophenyl)cyclopropyl]amino]-1-oxopentan-2-yl]-4-(1H-1,2,3-triazol-1-yl)benzamide bis(tosylate) salt [ No CAS ]
  • 12
  • [ 1314324-00-9 ]
  • (1R,2S)-2-(4-fluorophenyl)cyclopropan-1-amine [ No CAS ]
YieldReaction ConditionsOperation in experiment
With sodium hydroxide; In dichloromethane; water;Inert atmosphere; A 12-L, glass round bottom flask was equipped with a N2 bleed. The flask was charged with DCM (2510 mL), (li?,25)-2-(4-fluorophenyl)cyclopropan-l-amine (0625) hydrochloride (505.00 g) and 2 N NaOH solution (NaOH, 224.10 g and purified water, 2810 mL). The contents of the flask were allowed to stir 15 minutes and dissolution was confirmed. The layers were allowed to separate and the aqueous phase was extracted with DCM (1280 mL). The combined organic phase appeared as an opaque liquid, which was transferred to a rotary evaporator bulb and concentrated to a residue at < 40 C under vacuum. The bulb was dried at 25 ± 5 C under vacuum to afford Compound 9 (413 g, 101%) as an orange oil.
 

Historical Records

Technical Information

Categories

Similar Product of
[ 1314324-00-9 ]

Chemical Structure| 220349-80-4

A996525 [220349-80-4]

(1R,2S)-2-(4-Fluorophenyl)cyclopropanamine

Reason: Free-salt

Related Functional Groups of
[ 1314324-00-9 ]

Fluorinated Building Blocks

Chemical Structure| 879324-66-0

A638067 [879324-66-0]

2-(4-Fluorophenyl)cyclopropanamine hydrochloride

Similarity: 1.00

Chemical Structure| 26568-26-3

A719446 [26568-26-3]

trans-2-(4-Fluorophenyl)cyclopropanamine hydrochloride

Similarity: 1.00

Chemical Structure| 1157139-62-2

A156455 [1157139-62-2]

2-(3-Fluorophenyl)cyclopropanamine

Similarity: 0.97

Chemical Structure| 220349-80-4

A996525 [220349-80-4]

(1R,2S)-2-(4-Fluorophenyl)cyclopropanamine

Similarity: 0.97

Chemical Structure| 879396-75-5

A442329 [879396-75-5]

2-(4-Fluorophenyl)cyclopropanamine

Similarity: 0.97

Aryls

Chemical Structure| 879324-66-0

A638067 [879324-66-0]

2-(4-Fluorophenyl)cyclopropanamine hydrochloride

Similarity: 1.00

Chemical Structure| 26568-26-3

A719446 [26568-26-3]

trans-2-(4-Fluorophenyl)cyclopropanamine hydrochloride

Similarity: 1.00

Chemical Structure| 1157139-62-2

A156455 [1157139-62-2]

2-(3-Fluorophenyl)cyclopropanamine

Similarity: 0.97

Chemical Structure| 220349-80-4

A996525 [220349-80-4]

(1R,2S)-2-(4-Fluorophenyl)cyclopropanamine

Similarity: 0.97

Chemical Structure| 879396-75-5

A442329 [879396-75-5]

2-(4-Fluorophenyl)cyclopropanamine

Similarity: 0.97

Amines

Chemical Structure| 879324-66-0

A638067 [879324-66-0]

2-(4-Fluorophenyl)cyclopropanamine hydrochloride

Similarity: 1.00

Chemical Structure| 26568-26-3

A719446 [26568-26-3]

trans-2-(4-Fluorophenyl)cyclopropanamine hydrochloride

Similarity: 1.00

Chemical Structure| 1157139-62-2

A156455 [1157139-62-2]

2-(3-Fluorophenyl)cyclopropanamine

Similarity: 0.97

Chemical Structure| 220349-80-4

A996525 [220349-80-4]

(1R,2S)-2-(4-Fluorophenyl)cyclopropanamine

Similarity: 0.97

Chemical Structure| 879396-75-5

A442329 [879396-75-5]

2-(4-Fluorophenyl)cyclopropanamine

Similarity: 0.97